30 participants
Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2007-11-01
- Start Date:
- 2006-01-31
Conditions
- Chronic Hepatitis C Infection
- Fatty Liver
Interventions
- DRUG
No Results Yet